{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:09:38Z","timestamp":1794330578632,"version":"4.9.0"},"reference-count":31,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C19677\/A12617"],"award-info":[{"award-number":["C19677\/A12617"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>While there are several prognostic classifiers, to date, there are no validated predictive models that inform treatment selection for oropharyngeal squamous cell carcinoma (OPSCC).<\/jats:p>\n                    <jats:p>Our aim was to develop clinical and\/or biomarker predictive models for patient outcome and treatment escalation for OPSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Design:<\/jats:title>\n                    <jats:p>We retrospectively collated clinical data and samples from a consecutive cohort of OPSCC cases treated with curative intent at ten secondary care centers in United Kingdom and Poland between 1999 and 2012. We constructed tissue microarrays, which were stained and scored for 10 biomarkers. We then undertook multivariable regression of eight clinical parameters and 10 biomarkers on a development cohort of 600 patients. Models were validated on an independent, retrospectively collected, 385-patient cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 985 subjects (median follow-up 5.03 years, range: 4.73\u20135.21 years) were included. The final biomarker classifier, comprising p16 and survivin immunohistochemistry, high-risk human papillomavirus (HPV) DNA in situ hybridization, and tumor-infiltrating lymphocytes, predicted benefit from combined surgery + adjuvant chemo\/radiotherapy over primary chemoradiotherapy in the high-risk group [3-year overall survival (OS) 63.1% vs. 41.1%, respectively, HR = 0.32; 95% confidence interval (CI), 0.16\u20130.65; P = 0.002], but not in the low-risk group (HR = 0.4; 95% CI, 0.14\u20131.24; P = 0.114). On further adjustment by propensity scores, the adjusted HR in the high-risk group was 0.34, 95% CI = 0.17\u20130.67, P = 0.002, and in the low-risk group HR was 0.5, 95% CI = 0.1\u20132.38, P = 0.384. The concordance index was 0.73.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We have developed a prognostic classifier, which also appears to demonstrate moderate predictive ability. External validation in a prospective setting is now underway to confirm this and prepare for clinical adoption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1078-0432.ccr-23-1013","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:43:55Z","timestamp":1700041435000},"page":"356-367","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study"],"prefix":"10.1158","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5544-6224","authenticated-orcid":false,"given":"Hisham","family":"Mehanna","sequence":"first","affiliation":[{"name":"1Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-4016","authenticated-orcid":false,"given":"Davy","family":"Rapozo","sequence":"additional","affiliation":[{"name":"2National Cancer Institute of Brazil, Rio de Janeiro, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8897-5747","authenticated-orcid":false,"given":"Sandra V.","family":"von Zeidler","sequence":"additional","affiliation":[{"name":"3Pathology Department and Biotechnology Post-graduation Program, Federal University of Esp\u00edrito Santo, Vit\u00f3ria, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6014-348X","authenticated-orcid":false,"given":"Kevin J.","family":"Harrington","sequence":"additional","affiliation":[{"name":"4The Royal Marsden\/The Institute of Cancer Research National Institute of Health Research Biomedical Research Centre, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8152-816X","authenticated-orcid":false,"given":"Stuart C.","family":"Winter","sequence":"additional","affiliation":[{"name":"5Department of ENT-Head and Neck Surgery, Churchill Hospital, Nuffield Department of Surgery, University of Oxford, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-4916","authenticated-orcid":false,"given":"Andrew","family":"Hartley","sequence":"additional","affiliation":[{"name":"6Hall-Edwards Radiotherapy Research Group, University Hospitals Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-6117","authenticated-orcid":false,"given":"Paul","family":"Nankivell","sequence":"additional","affiliation":[{"name":"1Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-6038","authenticated-orcid":false,"given":"Andrew G.","family":"Schache","sequence":"additional","affiliation":[{"name":"7Northwest Cancer Research Centre, Department of Molecular & Clinical Cancer Medicine, University of Liverpool Head & Neck Unit, University Hospital Aintree, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-0213","authenticated-orcid":false,"given":"Philip","family":"Sloan","sequence":"additional","affiliation":[{"name":"8Center for Oral Health Research, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-0048","authenticated-orcid":false,"given":"Edward W.","family":"Odell","sequence":"additional","affiliation":[{"name":"9Head and Neck Pathology, King's College London, Guy's Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-7422","authenticated-orcid":false,"given":"Selvam","family":"Thavaraj","sequence":"additional","affiliation":[{"name":"10Faculty of Dental, Oral and Craniofacial Sciences, King's College London, London, United Kingdom."},{"name":"11Head and Neck Pathology at Guy's & St Thomas' Hospital NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7873-0877","authenticated-orcid":false,"given":"Keith D.","family":"Hunter","sequence":"additional","affiliation":[{"name":"12Liverpool Head and Neck Centre, Molecular and Clinical Medicine, University of Liverpool, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-4103","authenticated-orcid":false,"given":"Ketan A.","family":"Shah","sequence":"additional","affiliation":[{"name":"13Department of Cellular Pathology, John Radcliffe Hospital, Oxford, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-7335","authenticated-orcid":false,"given":"Gareth J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"14Cancer Sciences Unit, University of Southampton, University Road, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9947-1985","authenticated-orcid":false,"given":"Anna","family":"Long","sequence":"additional","affiliation":[{"name":"15Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6657-9884","authenticated-orcid":false,"given":"Rasoul","family":"Amel-Kashipaz","sequence":"additional","affiliation":[{"name":"16University Hospitals Birmingham, Edgbaston, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-8456","authenticated-orcid":false,"given":"Rachel M.","family":"Brown","sequence":"additional","affiliation":[{"name":"16University Hospitals Birmingham, Edgbaston, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-9355","authenticated-orcid":false,"given":"Brendan","family":"Conn","sequence":"additional","affiliation":[{"name":"17Royal Infirmary of Edinburgh, Edinburgh, Scotland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-5307","authenticated-orcid":false,"given":"Gillian L.","family":"Hall","sequence":"additional","affiliation":[{"name":"18Guy\u2019s Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7157-7080","authenticated-orcid":false,"given":"Paul","family":"Matthews","sequence":"additional","affiliation":[{"name":"19Department of Pathology, University Hospitals Coventry and Warwickshire, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4363-3135","authenticated-orcid":false,"given":"Justin","family":"Weir","sequence":"additional","affiliation":[{"name":"20Department of Cellular Pathology, Charing Cross Hospital, Imperial College Healthcare Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-0161","authenticated-orcid":false,"given":"Yen","family":"Yeo","sequence":"additional","affiliation":[{"name":"21Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-5772","authenticated-orcid":false,"given":"Miranda","family":"Pring","sequence":"additional","affiliation":[{"name":"22Bristol Dental School, University of Bristol, Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-3449","authenticated-orcid":false,"given":"Catharine M.L.","family":"West","sequence":"additional","affiliation":[{"name":"23Division of Cancer Studies, University of Manchester, Christie Hospital NHS Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7732-145X","authenticated-orcid":false,"given":"James","family":"McCaul","sequence":"additional","affiliation":[{"name":"24Department of Maxillofacial and Head and Neck Surgery, Queen Elizabeth II Hospital, Glasgow, Scotland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3937-5315","authenticated-orcid":false,"given":"Pawel","family":"Golusinski","sequence":"additional","affiliation":[{"name":"25Department of Otolaryngology and Maxillofacial Surgery, University of Zielona Gora, Zielona Gora, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-4497","authenticated-orcid":false,"given":"Alice","family":"Sitch","sequence":"additional","affiliation":[{"name":"26Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom."},{"name":"27NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8235-2116","authenticated-orcid":false,"given":"Rachel","family":"Spruce","sequence":"additional","affiliation":[{"name":"28University of Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-7427","authenticated-orcid":false,"given":"Nikolaos","family":"Batis","sequence":"additional","affiliation":[{"name":"1Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6919-9906","authenticated-orcid":false,"given":"Jennifer L.","family":"Bryant","sequence":"additional","affiliation":[{"name":"1Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4955-5299","authenticated-orcid":false,"given":"Jill M.","family":"Brooks","sequence":"additional","affiliation":[{"name":"1Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-6013","authenticated-orcid":false,"given":"Terence M.","family":"Jones","sequence":"additional","affiliation":[{"name":"29Northwest Cancer Research Centre, Department of Molecular & Clinical Cancer Medicine, University of Liverpool Head & Neck Unit, University Hospital Aintree, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-406X","authenticated-orcid":false,"given":"Francesca","family":"Buffa","sequence":"additional","affiliation":[{"name":"30Department of Oncology, University of Oxford, Oxford, United Kingdom."},{"name":"31Department of Computing Sciences, Bocconi University, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6685-5480","authenticated-orcid":false,"given":"Syed","family":"Haider","sequence":"additional","affiliation":[{"name":"30Department of Oncology, University of Oxford, Oxford, United Kingdom."},{"name":"32The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4491-6865","authenticated-orcid":false,"given":"Max","family":"Robinson","sequence":"additional","affiliation":[{"name":"8Center for Oral Health Research, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"2024011708122523000_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"key":"2024011708122523000_bib2","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"2024011708122523000_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.oraloncology.2015.01.002","article-title":"Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025","volume":"51","author":"Louie","year":"2015","journal-title":"Oral Oncol"},{"key":"2024011708122523000_bib4","doi-asserted-by":"crossref","first-page":"E1863","DOI":"10.1002\/hed.24336","article-title":"Geographic variation in human papillomavirus-related oropharyngeal cancer: data from 4 multinational randomized trials","volume":"38","author":"Mehanna","year":"2016","journal-title":"Head Neck"},{"key":"2024011708122523000_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2013systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"2024011708122523000_bib6","article-title":"Meeting IWGotEoCRtH, Organization WH, Cancer IAfRo","volume-title":"Human papillomaviruses.","author":"HumansIWGotEoCRt","year":"2007"},{"key":"2024011708122523000_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"2024011708122523000_bib8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/bjc.2015.139","article-title":"Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe","volume":"112","author":"Rietbergen","year":"2015","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib9","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1017\/S0022215116000505","article-title":"Oropharyngeal cancer: United Kingdom national multidisciplinary guidelines","volume":"130","author":"Mehanna","year":"2016","journal-title":"J Laryngol Otol"},{"key":"2024011708122523000_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"key":"2024011708122523000_bib11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/hed.22950","article-title":"Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis","volume":"35","author":"Rainsbury","year":"2013","journal-title":"Head Neck"},{"key":"2024011708122523000_bib12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"2024011708122523000_bib13","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2016.72.0748","article-title":"Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer","volume":"35","author":"Fakhry","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024011708122523000_bib14","volume-title":"NCCN guidelines for treatment of cancer by site","author":"NCCNetwork","year":"2014"},{"key":"2024011708122523000_bib15","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"2024011708122523000_bib16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"2024011708122523000_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/bjc.2014.639","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"112","author":"Collins","year":"2015","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib19","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/0008-5472.CAN-16-0633","article-title":"HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology","volume":"76","author":"Schache","year":"2016","journal-title":"Cancer Res"},{"key":"2024011708122523000_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/his.12118","article-title":"Guidelines and considerations for conducting experiments using tissue microarrays","volume":"62","author":"Ilyas","year":"2013","journal-title":"Histopathology"},{"key":"2024011708122523000_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"Ward","year":"2014","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/01621459.1977.10480613","article-title":"Efficiency of Cox's likelihood function for censored data","volume":"72","author":"Efron","year":"1977","journal-title":"J Am Stat Assoc"},{"key":"2024011708122523000_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02841860310005020","article-title":"Evaluation of objective measures of smoking status\u2013a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy","volume":"42","author":"Hald","year":"2003","journal-title":"Acta Oncol"},{"key":"2024011708122523000_bib24","first-page":"576","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume-title":"Nature","author":"Cancer Genome Atlas Network","year":"2015"},{"key":"2024011708122523000_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2024011708122523000_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41416-019-0414-9","article-title":"Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach","volume":"120","author":"Craig","year":"2019","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis","volume":"24","author":"Mehanna","year":"2023","journal-title":"Lancet Oncol"},{"key":"2024011708122523000_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2024011708122523000_bib29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br J Cancer"},{"key":"2024011708122523000_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"2024011708122523000_bib31","doi-asserted-by":"crossref","first-page":"e0116517","DOI":"10.1371\/journal.pone.0116517","article-title":"Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-23-1013\/3382334\/ccr-23-1013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/doi\/10.1158\/1078-0432.CCR-23-1013\/3388234\/ccr-23-1013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/30\/2\/356\/3404279\/356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/30\/2\/356\/3404279\/356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T03:12:50Z","timestamp":1705461170000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/30\/2\/356\/733194\/Developing-and-Validating-a-Multivariable"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,23]]},"published-print":{"date-parts":[[2024,1,17]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-23-1013","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1078-0432.25011377","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011377.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011380","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011386.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011380.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011383.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011371","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011389.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.25011374.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.c.7029299","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.7029299.v1","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}